Drug Discovery - Webinar: Advanced Analytical Technologies to Expedite the Development of ADCs |
|
|
|
|
|
|
The latest drug discovery news from News Medical |
|
|
|
![](https://www.azonetwork.com/newsletters/graphics/newsletter_section_divider_white_arrow.gif) | |
Automated Counting of Hepatocytes
DeNovix scientists have developed a unique software algorithm for the CellDrop™ Automated Cell Counter to deliver rapid and reliable hepatocyte counts.
Using a simple mix-and-measure fluorescence assay, the CellDrop Hepatocytes App easily identifies:
- Live and Dead Hepatocytes
- Lymphocytes
- Free Nuclei
- Debris
| |
|
|
|
![](https://www.azonetwork.com/newsletters/graphics/newsletter_section_divider_gray_arrow.gif) | |
|
|
Webinar: Advanced Analytical Technologies to Expedite the Development of ADCs
Antibody drug conjugates (ADCs) play a vital role in the growth and advancement of cancer treatments and therapeutics. A critical step in the development process for an ADC is establishing scientifically sound analytical methods that measure key product quality attributes to support pre-clinical activities and downstream clinical release and stability testing. These advancing technologies and methods can expedite an early-phase biologics’ path to IND by removing analytical method development from the critical path.
Join us in this webinar as we explore the methods and technologies needed to advance ADC development and characterization.
|
|
| | ![](https://www.azonetwork.com/newsletters/graphics/newsletter_horizontal_divider_white_bg.gif) | | | | How is AI Transforming Drug Discovery? The use of innovative AI tools has the potential to revolutionize this age-old process at almost every stage, including target identification, molecular simulations, prediction of drug properties, de novo drug design, candidate drug prioritization, and synthesis pathway generation. | |
|
|
|
![](https://www.azonetwork.com/newsletters/graphics/newsletter_section_divider_white_arrow.gif) | | Process validation is crucial for ensuring the quality of final products and the safety of these processes for manufacturing personnel and consumers in the pharmaceutical, medical device, and biotechnology industries. | | | | The latest developments in SPR-based biosensors and their applications in drug discovery. | | | | Adopting sustainable practices in the pharmaceutical industry has many benefits and reduces its environmental impact, such as improving efficiency, saving costs, and meeting regulatory requirements. | | | | Organ-on-chip (OoC) are microfluidic in vitro culture systems that mimic the physiological properties of human organs, providing insight into the function or pathophysiology of different organs. | | | | Tablet coatings act as a drug carrier, a system capable of incorporating a specific quantity of nutraceutical, cosmetical, and/or pharmaceutical agents to improve their pharmacokinetic properties. | |
|
|
|
|
![](https://www.azonetwork.com/newsletters/graphics/newsletter_section_divider_white_arrow.gif) | | How would you rate today's newsletter?
| |
|
|
|
|